Trospium
Back to searchMolecule Structure
Scientific Name
Trospium
Description of the Drug
Trospium is an antimuscarinic agent used to treat the symptoms of overactive bladder (OAB).
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00209
http://www.drugbank.ca/drugs/DB00209
Brand Name(s)
Not Available
Company Owner(s)
Apotex Inc, Padagis Us Llc, Glenmark Generics Ltd, Invagen Pharmaceuticals Inc, Actavis Laboratories Fl Inc, Amta Labs Ltd, Upsher Smith Laboratories Llc, Zameer Pharmaceuticals Llc, Granules Pharmaceuticals Inc, Allergan Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Muscarinic acetylcholine receptor M3 | SINGLE PROTEIN | ANTAGONIST | CHEMBL245 |
Muscarinic acetylcholine receptor M2 | SINGLE PROTEIN | ANTAGONIST | CHEMBL211 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL2447242 | |
DrugBank | DB00209 | |
Nikkaji | J247.002K | |
EPA CompTox Dashboard | DTXSID6048337 | |
DrugCentral | 2776 | |
rxnorm | TROSPIUM | TROSPIUM CHLORIDE |
ChEBI | 145791 | |
ZINC | ZINC000100016084 |